n Cardiovascular Journal of South Africa - Rosuvastatin achieves new standards in lipid management : drug trends in cardiology

Volume 14, Issue 3
  • ISSN : 1680-0745



Extracted from text ... AstraZeneca has broadcast internationally the data from the statin therapies for the Elevated Lipid Levels compared Across dose ranges to Rosuvastatin (STELLAR) and Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapy MERCURY I) studies. These evaluated the efficacy of specific doses and the dose range of rosuvastatin relative to atorvastatin, simvastatin and pravastatin in hypercholesterolaemic patients. Speaking from the American Cardiology Congress in Chicago, Dr Peter Jones, associate professor at Baylor College of Medicine, Houston, Texas, outlined the structure of the STELLAR study in which 2 431 patients from 182 centres were randomised to 15 different groups, each of which ..

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error